首页> 外文期刊>JMIR mHealth and uHealth >A Wearable Technology Delivering a Web-Based Diabetes Prevention Program to People at High Risk of Type 2 Diabetes: Randomized Controlled Trial
【24h】

A Wearable Technology Delivering a Web-Based Diabetes Prevention Program to People at High Risk of Type 2 Diabetes: Randomized Controlled Trial

机译:一种可穿戴技术,将网络基糖尿病预防计划提供给2型糖尿病的高风险:随机对照试验

获取原文
           

摘要

Background Intensive lifestyle interventions are effective in reducing the risk of type 2 diabetes, but the implementation of learnings from landmark studies is expensive and time consuming. The availability of digital lifestyle interventions is increasing, but evidence of their effectiveness is limited. Objective This randomized controlled trial (RCT) aimed to test the feasibility of a web-based diabetes prevention program (DPP) with step-dependent feedback messages versus a standard web-based DPP in people with prediabetes. Methods We employed a two-arm, parallel, single-blind RCT for people at high risk of developing diabetes. Patients with a hemoglobin Asub1c/sub (HbAsub1c/sub) level of 39-47 mmol/mol were recruited from 21 general practices in London. The intervention integrated a smartphone app delivering a web-based DPP course with SMS texts incorporating motivational interviewing techniques and step-dependent feedback messages delivered via a wearable device over 12 months. The control group received the wearable technology and access to the web-based DDP but not the SMS texts. As this was a feasibility study, the primary aim was to estimate potential sample size at different stages of the study, including the size of the target study population and the proportion of participants who consented, were randomized, and completed follow-up. We also measured the main outcomes for a full-scale RCT, namely, change in weight and physical activity at 6- and 12-month follow-ups, and secondary outcomes, including changes in the HbAsub1c/sub level, blood pressure, waist circumference, waist-to-hip ratio, and lipid levels. Results We enrolled 200 participants: 98 were randomized to the intervention and 102 were randomized to the control group. The follow-up rate was higher in the control group (87/102, 85.3%) than in the intervention group (69/98, 70%) at 12 months. There was no treatment effect on weight at 6 months (mean difference 0.15; 95% CI ?0.93 to 1.23) or 12 months (mean difference 0.07 kg; 95% CI ?1.29 to 1.44) or for physical activity levels at 6 months (mean difference ?382.90 steps; 95% CI ?860.65 to 94.85) or 12 months (mean difference 92.64 steps; 95% CI ?380.92 to 566.20). We did not observe a treatment effect on the secondary outcomes measured at the 6-month or 12-month follow-up. For the intervention group, the mean weight was 92.33 (SD 15.67) kg at baseline, 91.34 (SD 16.04) kg at 6 months, and 89.41 (SD 14.93) kg at 12 months. For the control group, the mean weight was 92.59 (SD 17.43) kg at baseline, 91.71 (SD 16.48) kg at 6 months, and 91.10 (SD 15.82) kg at 12 months. In the intervention group, the mean physical activity was 7308.40 (SD 4911.93) steps at baseline, 5008.76 (SD 2733.22) steps at 6 months, and 4814.66 (SD 3419.65) steps at 12 months. In the control group, the mean physical activity was 7599.28 (SD 3881.04) steps at baseline, 6148.83 (SD 3433.77) steps at 6 months, and 5006.30 (SD 3681.1) steps at 12 months. Conclusions This study demonstrates that it is feasible to successfully recruit and retain patients in an RCT of a web-based DPP.
机译:背景技术强化生活方式干预措施可有效降低2型糖尿病的风险,但是从地标研究的学习实施昂贵且耗时。数字生活方式干预的可用性正在增加,但其有效性的证据有限。目的这一随机对照试验(RCT)旨在测试基于Web的糖尿病防止计划(DPP)与逐步的反馈消息的可行性,而PrediaBetes的标准基于Web的DPP。方法采用双臂,平行,单盲的RCT,适用于高危开发糖尿病的人。招募了血红蛋白A 1C (HBA 1c )39-47 mmol / mol的患者,从伦敦的21例普通实践中招募。干预集成了一个智能手机应用程序,提供了一种基于Web的DPP课程,其中包含通过可穿戴设备传递的动机文本,并通过可穿戴设备提供超过12个月的逐步依赖的反馈消息。对照组接收到可穿戴技术并访问基于Web的DDP,但不是SMS文本。由于这是一个可行性研究,主要目的是估算研究不同阶段的潜在样本量,包括目标研究人口的规模和所同意的参与者的比例随机化,并完成后续行动。我们还测量了满量程RCT的主要结果,即6-个月的后续行动和次要结果,包括HBA 1c 水平的变化,血压,腰围,腰部到臀部比和脂质水平。结果我们注册了200名参与者:98被随机化,干预,102分为对照组。对照组的后续速率高于12个月的干预组(87/102,85.3%),在干预组(69/98,70%)中。在6个月内没有治疗效果(平均差0.15; 95%ci?0.93至1.23)或12个月(平均差异为0.07kg; 95%ci?1.29至1.44)或6个月的身体活性水平(平均值差异?382.90步; 95%CI?860.65至94.85)或12个月(平均差异92.64步; 95%CI?380.92至566.20)。我们没有观察到在6个月或12个月随访中测量的二次结果的治疗效果。对于干预组,平均重量为92.33(SD 15.67)kg在基线,91.34(SD 16.04)Kg,6个月,12个月,89.41(SD 14.93)Kg。对于对照组,平均重量在基线的92.59(SD17.43)kg,91.71(SD 16.48)Kg在6个月,91.10(SD 15.82)Kg,12个月。在干预组中,平均体育活动为7308.40(SD 4911.93)基线,5008.76(SD 2733.22)步骤6个月,4814.66(SD 3419.65)步骤在12个月内。在对照组中,平均体育活率为7599.28(SD 3881.04)步骤,在基线,6148.83(SD 3433.77)步骤在6个月,5006.30(SD 3681.1)步骤12个月。结论本研究表明,在基于Web的DPP的RCT中成功招募和保留患者是可行的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号